• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非药物和药物干预对终末期肾病患者与肌肉减少症相关指标的影响:系统评价和荟萃分析。

The Effect of Non-Pharmacological and Pharmacological Interventions on Measures Associated with Sarcopenia in End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.

机构信息

York Trials Unit, Department of Health Sciences, University of York, York YO10 5DD, UK.

Department of Cardiovascular Sciences, University of Leicester, Leicester LE1 7RH, UK.

出版信息

Nutrients. 2022 Apr 27;14(9):1817. doi: 10.3390/nu14091817.

DOI:10.3390/nu14091817
PMID:35565785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9101978/
Abstract

This systematic review and meta-analysis provides a synthesis of the available evidence for the effects of interventions on outcome measures associated with sarcopenia in end-stage kidney disease (ESKD). Thirteen databases were searched, supplemented with internet and hand searching. Randomised controlled trials of non-pharmacological or pharmacological interventions in adults with ESKD were eligible. Trials were restricted to those which had reported measures of sarcopenia. Primary outcome measures were hand grip strength and sit-to-stand tests. Sixty-four trials were eligible (with nineteen being included in meta-analyses). Synthesised data indicated that intradialytic exercise increased hand grip strength (standardised mean difference, 0.58; 0.24 to 0.91; p = 0.0007; I2 = 40%), and sit-to-stand (STS) 60 score (mean difference, 3.74 repetitions; 2.35 to 5.14; p < 0.001; I2 = 0%). Intradialytic exercise alone, and protein supplementation alone, resulted in no statistically significant change in STS5 (−0.78 s; −1.86 to 0.30; p = 0.16; I2 = 0%), and STS30 (MD, 0.97 repetitions; −0.16 to 2.10; p = 0.09; I2 = 0%) performance, respectively. For secondary outcomes, L-carnitine and nandrolone-decanoate resulted in significant increases in muscle quantity in the dialysis population. Intradialytic exercise modifies measures of sarcopenia in the haemodialysis population; however, the majority of trials were low in quality. There is limited evidence for efficacious interventions in the peritoneal dialysis and transplant recipient populations.

摘要

本系统评价和荟萃分析综合了现有证据,评估了干预措施对终末期肾病(ESKD)患者与肌肉减少症相关的结局指标的影响。共检索了 13 个数据库,并辅以互联网和手工检索。纳入了 ESKD 成人患者非药物或药物干预的随机对照试验。试验仅限于报告肌肉减少症测量指标的试验。主要结局测量指标为手握力和坐站测试。有 64 项试验符合条件(其中 19 项被纳入荟萃分析)。综合数据表明,透间运动增加了手握力(标准化均数差,0.58;0.24 至 0.91;p = 0.0007;I2 = 40%)和坐站(STS)60 评分(平均差异,3.74 次;2.35 至 5.14;p < 0.001;I2 = 0%)。单独透间运动和单独蛋白质补充均未导致 STS5(-0.78 秒;-1.86 至 0.30;p = 0.16;I2 = 0%)和 STS30(MD,0.97 次;-0.16 至 2.10;p = 0.09;I2 = 0%)表现的统计学显著变化。对于次要结局,左卡尼汀和癸酸诺龙可增加透析人群的肌肉量。透间运动改变了血液透析人群肌肉减少症的测量指标;然而,大多数试验的质量较低。腹膜透析和移植受者人群中有效的干预措施证据有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/a68a5874cc5a/nutrients-14-01817-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/fa1e7275647b/nutrients-14-01817-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/a6104990bec4/nutrients-14-01817-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/b01993b519f8/nutrients-14-01817-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/bd449771d46d/nutrients-14-01817-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/c40c6c969736/nutrients-14-01817-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/1e59abc86e3f/nutrients-14-01817-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/74df93c23f50/nutrients-14-01817-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/781df87c779f/nutrients-14-01817-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/5e3c56e5518a/nutrients-14-01817-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/23edcc39f5d8/nutrients-14-01817-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/3ae004196f2a/nutrients-14-01817-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/de55dea0bf4c/nutrients-14-01817-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/8b8848ad44fe/nutrients-14-01817-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/b986f98a1adf/nutrients-14-01817-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/a68a5874cc5a/nutrients-14-01817-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/fa1e7275647b/nutrients-14-01817-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/a6104990bec4/nutrients-14-01817-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/b01993b519f8/nutrients-14-01817-g0A3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/bd449771d46d/nutrients-14-01817-g0A4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/c40c6c969736/nutrients-14-01817-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/1e59abc86e3f/nutrients-14-01817-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/74df93c23f50/nutrients-14-01817-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/781df87c779f/nutrients-14-01817-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/5e3c56e5518a/nutrients-14-01817-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/23edcc39f5d8/nutrients-14-01817-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/3ae004196f2a/nutrients-14-01817-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/de55dea0bf4c/nutrients-14-01817-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/8b8848ad44fe/nutrients-14-01817-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/b986f98a1adf/nutrients-14-01817-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc6/9101978/a68a5874cc5a/nutrients-14-01817-g011.jpg

相似文献

1
The Effect of Non-Pharmacological and Pharmacological Interventions on Measures Associated with Sarcopenia in End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.非药物和药物干预对终末期肾病患者与肌肉减少症相关指标的影响:系统评价和荟萃分析。
Nutrients. 2022 Apr 27;14(9):1817. doi: 10.3390/nu14091817.
2
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
3
The effect of Tai Chi in elderly individuals with sarcopenia and frailty: A systematic review and meta-analysis of randomized controlled trials.太极拳对伴有肌少症和衰弱的老年人的影响:系统评价和随机对照试验的荟萃分析。
Ageing Res Rev. 2022 Dec;82:101747. doi: 10.1016/j.arr.2022.101747. Epub 2022 Oct 9.
4
Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.终末期肾病透析患者中重组人促红细胞生成素治疗贫血的给药频率
Cochrane Database Syst Rev. 2002(4):CD003895. doi: 10.1002/14651858.CD003895.
5
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.
6
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.重组人促红细胞生成素用于透析前慢性肾衰竭患者的贫血治疗
Cochrane Database Syst Rev. 2001(4):CD003266. doi: 10.1002/14651858.CD003266.
7
Psychological and pharmacological interventions for depression in patients with coronary artery disease.冠心病患者抑郁的心理和药理学干预措施。
Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD008012. doi: 10.1002/14651858.CD008012.pub4.
8
Interventions for promoting habitual exercise in people living with and beyond cancer.促进癌症患者及康复者进行习惯性锻炼的干预措施。
Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.用于预防或治疗早期乳腺癌中芳香化酶抑制剂引起的肌肉骨骼症状的系统治疗。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD013167. doi: 10.1002/14651858.CD013167.pub2.

引用本文的文献

1
Sarcopenia in Peritoneal Dialysis: Prevalence, Pathophysiology, and Management Strategies.腹膜透析中的肌肉减少症:患病率、病理生理学及管理策略
Kidney Med. 2025 Mar 7;7(5):100989. doi: 10.1016/j.xkme.2025.100989. eCollection 2025 May.
2
Body Composition and Intradialytic Exercise in Kidney Disease: A Combined Analysis of the PEDAL and CYCLE-HD Randomised Controlled Trials.肾病患者的身体成分与透析期间运动:PEDAL和CYCLE-HD随机对照试验的联合分析
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13748. doi: 10.1002/jcsm.13748.
3
Prevalence and severity of sarcopenia in patients on maintenance hemodialysis: a cross-sectional study.

本文引用的文献

1
Clinical practice guideline exercise and lifestyle in chronic kidney disease.慢性肾脏病的临床实践指南:运动与生活方式
BMC Nephrol. 2022 Feb 22;23(1):75. doi: 10.1186/s12882-021-02618-1.
2
Seven months of aerobic intradialytic exercise training can prevent muscle loss in haemodialysis patients: an ultrasonography study.七个月的有氧运动透析内运动训练可预防血液透析患者肌肉丢失:一项超声研究。
Int Urol Nephrol. 2022 Feb;54(2):447-456. doi: 10.1007/s11255-021-02931-6. Epub 2021 Jun 28.
3
Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCT.
维持性血液透析患者肌少症的患病率和严重程度:一项横断面研究。
BMC Nephrol. 2024 Oct 29;25(1):385. doi: 10.1186/s12882-024-03836-z.
4
Comparisons of Intradialytic Exercise Versus Home-Based Exercise in Hemodialysis Patients: A Narrative Review.血液透析患者透析期间运动与家庭运动的比较:一项叙述性综述
Biomedicines. 2024 Oct 16;12(10):2364. doi: 10.3390/biomedicines12102364.
5
Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies.肌肉减少症的研究进展:机制、治疗靶点和干预策略。
Arch Pharm Res. 2024 Apr;47(4):301-324. doi: 10.1007/s12272-024-01493-2. Epub 2024 Apr 9.
6
Association between dietary magnesium intake and muscle mass among hypertensive population: evidence from the National Health and Nutrition Examination Survey.饮食镁摄入量与高血压人群肌肉量的关系:来自全国健康和营养调查的证据。
Nutr J. 2024 Mar 21;23(1):37. doi: 10.1186/s12937-024-00940-6.
7
External validation of the prediction model of intradialytic hypotension: a multicenter prospective cohort study.透析中低血压预测模型的外部验证:一项多中心前瞻性队列研究
Ren Fail. 2024 Dec;46(1):2322031. doi: 10.1080/0886022X.2024.2322031. Epub 2024 Mar 11.
8
Sarcopenic obesity is associated with adverse outcomes after kidney transplantation: a retrospective cohort study.肌肉减少性肥胖与肾移植后不良结局相关:一项回顾性队列研究。
Int Urol Nephrol. 2024 Aug;56(8):2565-2575. doi: 10.1007/s11255-024-03982-1. Epub 2024 Mar 2.
9
Perceptions of healthcare providers on benefits, risks and barriers regarding intradialytic exercise among haemodialysis patients.血液透析患者透析中运动的益处、风险和障碍感知:医护人员的观点。
Int J Qual Stud Health Well-being. 2024 Dec;19(1):2287597. doi: 10.1080/17482631.2023.2287597. Epub 2023 Dec 6.
10
Clinical features and molecular mechanism of muscle wasting in end stage renal disease.终末期肾病中肌肉减少症的临床特征和分子机制。
BMB Rep. 2023 Aug;56(8):426-438. doi: 10.5483/BMBRep.2023-0097.
运动方案改善接受血液透析的终末期肾病患者的生活质量:PEDAL RCT 研究。
Health Technol Assess. 2021 Jun;25(40):1-52. doi: 10.3310/hta25400.
4
A randomized controlled trial to investigate the effects of intra-dialytic cycling on left ventricular mass.一项随机对照试验,旨在研究透析中周期性运动对左心室质量的影响。
Kidney Int. 2021 Jun;99(6):1478-1486. doi: 10.1016/j.kint.2021.02.027. Epub 2021 Apr 8.
5
Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK Biobank study.肌肉减少症与慢性肾脏病患者死亡率和终末期肾病的关系:英国生物库研究。
J Cachexia Sarcopenia Muscle. 2021 Jun;12(3):586-598. doi: 10.1002/jcsm.12705. Epub 2021 May 5.
6
Effect of a Home-Based Exercise Program on Indices of Physical Function and Quality of Life in Elderly Maintenance Hemodialysis Patients.基于家庭的运动方案对老年维持性血液透析患者身体机能和生活质量指数的影响。
Kidney Blood Press Res. 2021;46(2):196-206. doi: 10.1159/000514269. Epub 2021 Mar 26.
7
Effects of dynamic and isometric resistance training protocols on metabolic profile in hemodialysis patients: a randomized controlled trial.动态和等长抗阻训练方案对血液透析患者代谢特征的影响:一项随机对照试验。
Appl Physiol Nutr Metab. 2021 Sep;46(9):1029-1037. doi: 10.1139/apnm-2020-0900. Epub 2021 Mar 2.
8
Effects of intradialytic cycling exercise on daily physical activity, physical fitness, body composition, and clinical parameters in high-volume online hemodiafiltration patients: a pilot randomized-controlled trial.在线血液透析滤过患者透析中周期性运动对日常体力活动、身体适应性、身体成分和临床参数的影响:一项初步随机对照试验。
Int Urol Nephrol. 2021 Feb;53(2):359-371. doi: 10.1007/s11255-020-02677-7. Epub 2020 Oct 31.
9
Effects of a resistance training program in kidney transplant recipients: A randomized controlled trial.抗阻训练计划对肾移植受者的影响:一项随机对照试验。
Scand J Med Sci Sports. 2021 Feb;31(2):473-479. doi: 10.1111/sms.13853. Epub 2020 Oct 23.
10
Effects of baru almond oil (Dipteryx alata Vog.) supplementation on body composition, inflammation, oxidative stress, lipid profile, and plasma fatty acids of hemodialysis patients: A randomized, double-blind, placebo-controlled clinical trial.巴鲁杏仁油(Dipteryx alata Vog.)补充对血液透析患者身体成分、炎症、氧化应激、血脂谱和血浆脂肪酸的影响:一项随机、双盲、安慰剂对照的临床试验。
Complement Ther Med. 2020 Aug;52:102479. doi: 10.1016/j.ctim.2020.102479. Epub 2020 Jun 11.